Spirometer Market Development And Business Intelligence
Summary
- Major factors influencing the growth of the market.
- Leading players & Top Segments.
- Geographic Overview.
Market growth influenced due to following factors-
- Rising global incidence of respiratory diseases.
- Increasing aging population.
- Technological shift in spirometer devices towards smartphone-based data acquisition.
Global market size-
According to the new market research report Spirometer Market is expected to reach $1,285 million by 2025, at a CAGR of 11.1%.
Leading Players-
The major players operating in this Spirometry Market are Hill-Rom, Inc. (US), Midmark Corp. (US), Futuremed (US), COSMED (OTCPK:ITALY), MGC Diagnostics Corporation (US), Vyaire Medical (US), Medical International Research (OTCPK:ITALY),Vitalograph (UK), ndd Medical Technologies (Zurich), Inc., Schiller AG (Switzerland), Jones Medical Instrument Company (US), Sibelmed (Spain), MIR, Recorders and Medicare Systems (India), Smiths Medical (US), Medline (US), Teleflex (US), CONTEC (CHINA), Fysiomed (Belgium), Medikro (Finland), Sdi Diagnostics (US), CHEST M.I. (Japan), Inc, FUKUDA SANGYO Co. Ltd. (Japan), Clarity Medical (India), and Guangzhou Medsinglong Medical Equipment Co., Ltd. (CHINA).
Top Market Segments-
Based on product, the spirometer products market is segmented into devices, consumables & accessories, and software.The consumables and accessories segment accounted for the largest share of the market in 2019.
Based on end user, the Spirometry Market is segmented into hospitals, clinical laboratories, home care settings, and industrial settings. The hospitals segment is expected to account for the highest share in 2019.
For Details, Download PDF Brochure
Geographic Overview -
The global market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). The North American market is expected to account for the highest market share in 2019. The large share of this market segment can be attributed to the increasing incidence of chronic respiratory diseases and the rising adoption of technologically advanced devices in the region.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.